When AI fails to thrive in healthcare, the problem is usually not with an algorithm. It’s with something deeper. Three unrelated opinion pieces authored by far-flung subject matter experts hit on this theme just this week.
Regulators said the shortages of neurosurgery devices are likely to extend until the end of the year. Medline recalled its neurosurgical patties due to a potential toxicity issue. The FDA said it's looking for alternatives.
Kevin Accola, MD, spoke to Cardiovascular Business about new 10-year data on the performance of surgical valves featuring Resilia tissue. The findings are good news for Edwards Lifesciences, which also includes the tissue on many of its TAVR devices.
As precision cardiology continues to evolve, the integration of advanced coronary computed tomography angiography (CCTA) and AI-driven analysis is fundamentally changing how we assess and manage coronary artery disease (CAD). Here is a closer look at how Heartflow Plaque Staging is leveraging Total Plaque Volume (TPV) to stratify patient risk.
Medical students are broadly familiar with digital health technologies. Relatedly, they believe AI will play a crucial role in the future of healthcare. These are good signs for the advancement of evidence-based medicine.
Two lines of Medtronic Neurosurgery EDMS kits are at risk of developing cracks that could expose patients to pathogens or cause cerebrospinal fluid to leak.
The checklist was created to walk researchers through every operational step of using portable MRI, from creating protocols to prepping patients, ensuring patient safety, handling incidental findings, data privacy and more.
When AI fails to thrive in healthcare, the problem is usually not with an algorithm. It’s with something deeper. Three unrelated opinion pieces authored by far-flung subject matter experts hit on this theme just this week.
Regulators said the shortages of neurosurgery devices are likely to extend until the end of the year. Medline recalled its neurosurgical patties due to a potential toxicity issue. The FDA said it's looking for alternatives.
